Cross-border trade — 10 things to know on May 26, 2026

1. Sheinbaum May 25 post-meeting: USMCA talks "advancing positively." After Greer's arrival in Mexico City, President Sheinbaum gave a first read on the first formal bilateral negotiating round — "advancing positively." The statement is short on specifics but useful as a market signal: May 25 is substantive engagement, not procedural launch. The agenda continues to revolve around rules of origin, critical-minerals collaboration, and the boundary conditions on §232 steel/aluminum derivative rates.

2. §122 is by design a bridge — expires when §301 takes over July 24. The §122 10% global surcharge implemented February 24 was designed as a transitional instrument — bridging the gap between SCOTUS striking down IEEPA tariffs on February 20 (Learning Resources v. Trump, 6-3) and the §301 16-economy investigation's July 24 action target. In other words, July 24 isn't just when §301 action lands — it's also when §122 retires by design. We had not made this architectural intent explicit in earlier entries; adding it today.

3. §122 may already be struck down by CIT — single-source signal pending verification. A retrospective Trade Compliance Resource Hub piece cites a May 7 Court of International Trade ruling declaring "Proclamation 11012" — the §122 implementing order, per the article — invalid as contrary to law. However, Proclamation 11012 is in most public records the IEEPA original, not §122. If verified, §122 would retire ahead of July 24, removing one layer of the §232 / §301 / §122 stack on China-origin goods. MOFCOM, USTR, and the White House have not commented publicly. Flagged for human review — primary CIT docket or mainstream financial press confirmation needed before action.

4. §301 exclusions on 178 Chinese products extended to November 10. USTR has extended the existing §301 (forced technology transfer) exclusion list covering 178 China-origin product categories through November 10, 2026 — exact alignment with the Busan-truce expiry date. The exclusion action is small in itself, but the date-alignment is a clear architectural signal: every China-tariff handle is being aligned to November 10 as the next major time anchor.

5. Beijing summit commercial deliverables are in execution. The $17B/year agricultural commitment and 200 Boeing aircraft order from the May 14-15 summit are now in execution stage. COFCO and other Chinese state buyers issued first major soybean orders in the latter half of May. Commercial-track follow-through is reasonably paced, but does not rewrite the tariff layer — the political-commercial separation the summit structured remains intact.

6. CAPE first refund landings still publicly unconfirmed. Fourteen days since Treasury's May 12 ACH start. Per CBP's "3-5 weeks ACH from liquidation/reliquidation" timeline, entries liquidated May 12-13 should hit accounts in early June at earliest. The absence of public confirmations from major importers is consistent with normal windowing, not anomaly.

7. The US-Mexico May 25 round runs through this week — granular outputs land midweek. USTR and Mexico's economy ministry will not publish daily updates. Three to four sub-agenda working groups complete first-round exchanges this week. A joint statement likely lands next Monday with more specific paths — particularly on whether "performance thresholds" on steel/aluminum derivatives get introduced as a negotiating mechanism.

8. §232 metals tiered system finishes month two in operation. The April 6 architecture — 50% on commodity / 25% on derivatives with ≥15% metal content / full exemption below — is operating without major controversy in its first full month. CBP's scope-ruling request queue is building; those rulings determine which HS codes land in the 25% tier versus 50% over the next 18 months.

9. §232 pharma 66 days from kickoff. The 100% rate goes live July 31 for Annex III's 17 companies. Other pharma companies follow September 29. Switzerland's 15% preferential tier holds. Ireland, India, China, Singapore, Belgium, Denmark, Germany, France, and Italy stay on the default 100%.

10. Busan-truce countdown 168 days — every architectural deadline is now visible. Put every milestone on one timeline: July 24 — §122 expires + §301 action lands; July 31 — §232 pharma Annex III 17 firms; September 29 — §232 pharma extension; late July to early August — §301 forced-labor determination; July 1 — USMCA trilateral review opens (multi-year tail); November 10 — Busan truce expires. The $30B per-side reciprocal reduction framework sits on the Busan-renewal negotiating table. Every one of these lines has to clock-align to November 10 before then.